2.5949
Universe Pharmaceuticals Inc stock is traded at $2.5949, with a volume of 373.
It is down -7.29% in the last 24 hours and down -18.60% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$2.88
Open:
$2.7151
24h Volume:
373
Relative Volume:
0.04
Market Cap:
$1.76M
Revenue:
$17.86M
Net Income/Loss:
$-3.67M
P/E Ratio:
-0.2561
EPS:
-10.1315
Net Cash Flow:
$-5.40M
1W Performance:
+5.12%
1M Performance:
-18.60%
6M Performance:
-28.42%
1Y Performance:
-42.83%
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
UPC
Universe Pharmaceuticals Inc
|
2.7151 | 1.87M | 17.86M | -3.67M | -5.40M | -10.13 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.91 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.275 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.64 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
80.65 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.77 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
Universe Pharmaceuticals (UPC) Surges 8%: Key Support and Resistance Levels to WatchCatalyst Driven Stocks - Newser
Gang Lai Discloses Stake at Universe Pharmaceuticals with 13.58% Holding - TradingView
Universe Pharmaceuticals (NASDAQ: UPC) CEO receives share grants under 2026 equity plan - Stock Titan
Universe Pharmaceuticals (NASDAQ: UPC) CEO Gang Lai reports 13.58% ownership in Schedule 13D - Stock Titan
Universe Pharmaceuticals Grants CEO Majority-Strengthening Equity Award Under 2026 Plan - TipRanks
UPC Stock Price, Quote & Chart | UNIVERSE PHARMACEUTICAL-CL A (NASDAQ:UPC) - ChartMill
Universe Pharmaceuticals (NASDAQ: UPC) CEO now holds 75% voting power - Stock Titan
TradingKey - TradingKey
UPC (Universe) points to strong generic drug sales momentum as key driver of its latest quarterly results.Subscription Growth - newser.com
Universe Pharmaceuticals Adopts 2026 Equity Incentive Plan to Align Talent and Shareholder Interests - TipRanks
Universe Colorbond Fencing Brisbane expands services - openPR.com
12 Health Care Stocks Moving In Thursday's After-Market SessionAdvanced Biomed (NASDAQ:ADVB), BNB Plus - Benzinga
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
Mattel’s Masters Of The Universe Diner Tour Highlights Brand And Valuation Story - Yahoo Finance
Jiawen Pang Net Worth (2026) - GuruFocus
Ding Zheng Net Worth (2026) - GuruFocus
Lin (lydia) Yang Net Worth (2026) - GuruFocus
Baochang Liu Net Worth (2026) - GuruFocus
Yongping Yu Net Worth (2026) - GuruFocus
Gang Lai Net Worth (2026) - GuruFocus
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Universe Pharmaceuticals (UPC) sets 2026 equity incentive plan with 84,500 shares - Stock Titan
Will Clearside Biomedical Inc benefit from geopolitical trendsMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
SGN PE Ratio & Valuation, Is SGN Overvalued - Intellectia AI
Market Outlook: Is TOMZ part of any major index2026 Trade Ideas & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Momentum: Can Universe Pharmaceuticals INC be the next market leader2026 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
SGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - Yahoo Finance
CDT PE Ratio & Valuation, Is CDT Overvalued - Intellectia AI
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Universe Pharmaceuticals Inc (UPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UPC Tests Support: Bearish Momentum Builds - Newser
UPC Should I Buy - Intellectia AI
CNSP PE Ratio & Valuation, Is CNSP Overvalued - Intellectia AI
Retail Surge: How Universe Pharmaceuticals INC stock compares to market leaders2026 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
EZGO PE Ratio & Valuation, Is EZGO Overvalued - Intellectia AI
UPC SEC FilingsUniverse Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sell Signal: Should you avoid WTBA stock right now2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Iterum Therapeutics PLC (ITRM) Stock Price, Quote, News & History - Benzinga
Chipmakers Recap: Is Addex Therapeutics Ltd Depositary Receipt stock a falling knife or bargain buyQuarterly Trade Review & Consistent Return Investment Signals - baoquankhu1.vn
Investor Mood: Is VLGEA benefiting from interest rate changes2026 Rallies & Reliable Trade Execution Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Portfolio Shifts: Should I invest in Universe Pharmaceuticals INC before earnings2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha
Mattel Unveils Full "Masters of the Universe" Product Line Ahead of Highly Anticipated Live-Action Film - Yahoo Finance
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
If You Invested $1,000 in AKANDA CORP (AKAN) - Stock Titan
Universe Pharmaceuticals (NASDAQ: UPC) director Zheng Ding files Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) CEO lists 3,467 Class B shares - Stock Titan
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):